- Home
- MDGL vs MTN Comparison
MDGL vs MTN Comparison
Compare MDGL & MTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- MTN
- Stock Information
- Founded
- MDGL 2011
- MTN 1997
- Country
- MDGL United States
- MTN United States
- Employees
- MDGL N/A
- MTN N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- MTN Services-Misc. Amusement & Recreation
- Sector
- MDGL Health Care
- MTN Consumer Discretionary
- Exchange
- MDGL Nasdaq
- MTN Nasdaq
- Market Cap
- MDGL 7.4B
- MTN 7.1B
- IPO Year
- MDGL N/A
- MTN 1997
- Fundamental
- Price
- MDGL $308.44
- MTN $184.48
- Analyst Decision
- MDGL Buy
- MTN Hold
- Analyst Count
- MDGL 14
- MTN 10
- Target Price
- MDGL $347.33
- MTN $205.30
- AVG Volume (30 Days)
- MDGL 355.8K
- MTN 666.6K
- Earning Date
- MDGL 10-31-2024
- MTN 12-09-2024
- Dividend Yield
- MDGL N/A
- MTN 4.82%
- EPS Growth
- MDGL N/A
- MTN 5.26
- EPS
- MDGL N/A
- MTN 6.16
- Revenue
- MDGL $76,813,000.00
- MTN $2,886,901,000.00
- Revenue This Year
- MDGL N/A
- MTN $5.61
- Revenue Next Year
- MDGL $194.49
- MTN $4.33
- P/E Ratio
- MDGL N/A
- MTN $29.90
- Revenue Growth
- MDGL N/A
- MTN 0.64
- 52 Week Low
- MDGL $168.25
- MTN $165.00
- 52 Week High
- MDGL $368.29
- MTN $236.92
- Technical
- Relative Strength Index (RSI)
- MDGL 51.11
- MTN 49.81
- Support Level
- MDGL $289.80
- MTN $187.99
- Resistance Level
- MDGL $315.09
- MTN $194.47
- Average True Range (ATR)
- MDGL 12.44
- MTN 6.51
- MACD
- MDGL -4.11
- MTN -1.21
- Stochastic Oscillator
- MDGL 48.58
- MTN 41.25
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
About MTN Vail Resorts Inc.
Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.